Displaying agenda in the event’s time zone (CET, GMT +2)

Tuesday, 29 June, 2021
Wednesday, 30 June, 2021


Keynote: Innovative Digital Patient Solutions for the Chronic Disease Patient

Today`s patients are aware, technology-driven, and well informed. Not only but especially chronic patients have a keen interest in assuming greater control over their own health, including the therapeutics they take. This changes the way they interact with their healthcare providers, payors, and pharmaceutical companies.

Pharmaceutical companies like Pfizer strive to leverage the unique potential of new technologies by engaging patients in their own healthcare decisions. This is enabled by innovative, patient centric digital health solutions such as connected medical devices, health apps or digitalized clinical trials. These can be rooted in e.g. AI technology, gamification technology, real-time data collection, behavioural science or novel sensors. In the end, this allows for continuous monitoring and will pave the way for improving long-term treatment outcomes, medication adherence and psychological health.

This presentation showcases how Pfizer leverages digital trends to connect with stakeholders in a different way in order to bring value to patients beyond medicine.

Presented by Pfizer

Innovation in Market Research

Presented by GlaxoSmithKline, Ipsen, and Stanford University


Healthcare Megatrends – Examining the Shift to the Next Era of Healthcare

Presented by Lifescience Dynamics

ROUNDTABLE: Integrating Market Research Insights Into Early Stage Development

Presented by Fresenius Kabi


Traditional to Digital, Patient Journey Mapping

Our paper is based on a use case where our client, a global medical devices and health care company, wanted us to create patient journey maps for women health targeting In vitro fertilisation (IVF) and Endometriosis focusing on women aged 25 years to 45 years. The strategic objective of our client was to increase the patient base for the USA and EU5.

Our client’s women health portfolio was facing intense competition and their strategy was to retain patients on their approved drugs. In this regard, the client wanted to understand the perception and emotional state of women targeting In vitro fertilisation (IVF) and Endometriosis suffering from irregular bleeding, heavy menstruation or pain during their journey.

After exploratory research and an in-depth understanding of client requirements, BA Health (Borderless Access’ healthcare R&A brand) proposed a patient journey mapping solution that included primary market research study and an online patient community.

Our unique solution of patient research combined with data analytics and verified using secondary research helped design patient journey IVF and endometriosis. Our proprietary methodology included CAWI and Community based data collection models to capture patient experiences across treatment stages for USA and EU5 markets

We created specific patient journey maps for IVF and endometriosis by target markets. Along with patient journey maps we created a treatment algorithm and consolidated treatment insights. Using patient segmentation approach, we designed 4 patient cohorts to evaluate which patient cohort can be targeted for higher retention.

Presented by Borderless Access

Evolving From Brand Tracking to Mini-Surveys to Deliver Actionable and Instant Insights

Traditional Brand performance tracking surveys are known for a big variety of metrics included.

What if we could reduce huge scope brand tracking to only 3-4 essential KPIs, which have the strongest connection to prescription behavior? Could that help us to deliver better insights in a more efficient way? We are going to share:
• The challenges of the brand tracking metrics evaluation and suggest a solution
• A practical example of building up mini-survey on the essential KPIs to get market insights in a fast and efficient way

Presented by Boehringer Ingelheim

Uncovering Medical Decision Drivers using Modern Neurotechnology

It is very hard for humans to verbalize their emotions elicited by and understanding of concepts such as medical information. Classic survey and focus group research relies on explicit statements which are based on the questionable assumption that physicians and patients understand the drivers of their own behavior.

Modern technologies from the neurosciences open a novel avenue to better understanding people. That is because neurotechnology accesses both conscious and unconscious processes of the mind’s emotional and decision systems.

This talk will present scientific and applied marketing research cases demonstrating how brain scans with physicians and patients were used to assess how people perceive medical information. The audience will learn how information should be structured to be understood, which emotional networks play a role in understanding information and how pharmaceutical companies have used brain scans combined with learnings from psychophysics and machine learning to improve medical information.

Presented by HFU Business School



Integrating the Patient Voice into Drug Development From the Start – Our Journey so Far

There is a new buzz word in our industry: Patient-focused Drug Development (PFDD). And it matches perfectly with UCB’s corporate motto to be inspired by patients and driven by science.

But how to put theory into practice? In 2020, we’ve embarked on a journey to integrate the patient perspective as early as possible into our R&D processes. You will hear:
• What challenge we started from
• How we set ourselves up for this adventure
• Where we are today – and what learnings we can build on

Presented by UCB

ROUNDTABLE: Forecasting Platforms

Presented by Amgen


Why Market Researchers Should Love Omnichannel Marketing

Presented by Fujirebio

“Don’t Stand So Close to Me” – Have Healthcare’s Views of Remote Connectivity to Patients Changed?

Remote connectivity to patients can be of benefit in terms of patient adherence, clinical data transfer and management of medical devices but stakeholders (Pharma, HCPs, patients, payors) have often raised concerns and uptake can be slow.

The challenges of 2020 have led to problems for all healthcare stakeholders but this presentation will focus on the opportunities that have grown
• HCPs see more clearly the need for remote monitoring of patients with long term conditions as they were prevented from seeing patients face to face
• Views about privacy and other regulations are changing and patient acceptability may increase
• Payors may be willing to engage in different reimbursement models as patient pathways change
• Pharma has needed to focus on new models of communication with HCPs and others as well as the need to provide innovative patient engagement approaches for new products and devices
• Market research must assess opportunities for increased remote connectivity and test acceptability and ease of use

Presented by Baxter


Successful Integration of Supply Chain Operations Post Significant Merger/Acquisition

How can supply chain functions plan for successful integration following a significant merger or acquisition.

Presented by Bristol-Myers Squibb and ZS Associates

Summary & Key Takeaways

Presented by MSD, Roche, and Stanford University